BioAge Labs (BIOA) Non-Current Assets (2023 - 2026)
BioAge Labs (BIOA) reported Non-Current Assets of $5.8 million for Q1 2026, down 69.55% on a YoY basis from $19.0 million in Q1 2025, and down 28.43% sequentially from $8.1 million in Q4 2025.
BioAge Labs (BIOA) Non-Current Assets (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Non-Current Assets data on file, last reported at $5.8 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 69.55% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $48.6 million (up 124.07% YoY), and the FY2025 full-year result was $8.1 million, up 615.83% from the prior year.
- Non-Current Assets eased to $5.8 million in Q1 2026, from $8.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $20.5 million in Q2 2025 to a low of $618000.0 in Q4 2023.
- A 4-year average of $8.8 million and a median of $6.9 million in 2025 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets soared 1460.39% in 2025 and tumbled 69.55% in 2026, its largest moves.
- Tracing BIOA's Non-Current Assets over 4 years: stood at $618000.0 in 2023, then surged by 83.01% to $1.1 million in 2024, then surged by 615.83% to $8.1 million in 2025, then fell by 28.43% to $5.8 million in 2026.
- Business Quant data shows BIOA's Non-Current Assets at $5.8 million in Q1 2026, $8.1 million in Q4 2025, and $14.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | 5.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.79 Mn |
| Dec 31, 2025 | 8.10 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 20.45 Mn |
| Mar 31, 2025 | 19.03 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 914,000.00 |
| Dec 31, 2023 | 618,000.00 |